DAIC Articles

The Farapulse pulsed field ablation (PFA) system ablates heart tissue using the creation of an electric field instead of using thermal energy sources such as radiofrequency ablation or cryoablation.

New release of electrophysiology imaging and mapping system combines faster, higher resolution imaging for Medtronic cryoablation procedures

Biosense Webster’s Carto Prime Mapping Module offers new tools to help shorten ablation time. Left is an example of Coherent imaging showing conduction identification, conduction velocity vectors and conduction barrier zones.

August 21, 2020 — The U.S. Centers for Medicare and Medicaid Services (CMS) proposed updates to coverage policies for total artificial hearts (TAH) and ventricular assist devices (VAD), both of which are used to treat patients with life-threatening advanced heart failure. The agency said the changes will help expand the use of these devices to […]

Building on their existing cooperation Ziehm wants to expand cardiovascular image fusion and 3-D navigation capabilities.

August 18, 2020 — Philips Healthcare introduced its new OmniWire, the world’s first solid core fractional flow reserve (FFR) pressure wire for coronary artery interventional procedures. With its solid core construction, physicians can more easily maneuver the wire in the patient’s circulatory system to measure blood pressure along the vessel and guide the delivery of […]

The U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) this week for the use of Abiomed Impella left ventricular (LV) support systems to providing temporary LV unloading and support to treat critical coronavirus (COVID‐19) patients who are already on extracorporeal membrane oxygenation (ECMO) treatment.

Final results from the UNTOUCHED study of the Emblem Subcutaneous Implantable Defibrillator (S-ICD) System were presented at Heart Rhythm Society (HRS) 2020 Science virtual meeting.

There is a major challenge in balancing the risk of a delaying a needed valvular and structural heart disease (SHD) procedures against the risk of a susceptible patient being brought into the hospital during the COVID-19 pandemic.

The scientific community is learning more about the impact and interaction of cardiovascular diseases with novel coronavirus (COVID-19, SARS-CoV-2), including the impact of drug therapies being used and their negative cardiovascular impact.